Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cidofovir sub-protocol for hospitalized patients with mpox or smallpox
jRCTs031240658Recruiting
- Sponsor
- Japan Agency for Medical Research and Development
- Start
- Feb 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of cidofovir in mpox and smallpox, sponsored by Japan Agency for Medical Research and Development. Primary endpoint: Virologic clearance in skin lesions at day 14. Started Feb 2025; status: recruiting.
02
Drugs
cidofovir
03
Conditions
mpoxsmallpox
Beyond the preview
Go deeper on jRCTs031240658.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs031240658.